New hope to save bladders from cancer surgery
NCT ID NCT07475806
Summary
This study is testing whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can effectively treat muscle-invasive bladder cancer so patients can keep their bladder. The goal is to see how many people have their cancer disappear and how many still have their bladder intact two years later, avoiding the standard surgery to remove it. It is for adults who are eligible for bladder removal surgery but want to explore an alternative.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.